Human Molecular Genetics, 2002, Vol. 11, No. 19 2331-2339
© 2002 Oxford University Press
ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg


1Institute of Physiology, University of Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland, 2Institute of Microbiology, Swiss Federal Institute of Technology, Schmelzbergstrasse 7, 8092 Zürich, Switzerland and 3Department of Clinical Genetics, University Hospital of Copenhagen, 9 Blegdamsvej, 2100 Copenhagen, Denmark
Received May 22, 2002; Accepted July 11, 2002
In the endoplasmic reticulum (ER) of eukaryotes, N-linked glycans are first assembled on the lipid carrier dolichyl pyrophosphate. The GlcNAc2Man9Glc3 oligosaccharide is transferred to selected asparagine residues of nascent polypeptides. Defects along the biosynthetic pathway of N-glycans are associated with severe multisystemic syndromes called congenital disorders of glycosylation. Here, we describe a deficiency in the ALG12 ER
1,6-mannosyltransferase resulting in a novel type of glycosylation disorder. The severe disease was identified in a child presenting with psychomotor retardation, hypotonia, growth retardation, dysmorphic features and anorexia. In the patient's fibroblasts, the biosynthetic intermediate GlcNAc2Man7 oligosaccharide was detected both on the lipid carrier dolichyl pyrophosphate and on newly synthesized glycoproteins, thus pointing to a defect in the dolichyl pyrophosphateGlcNAc2Man7-dependent ALG12
1,6 mannosyltransferase. Analysis of the ALG12 cDNA in the CDG patient revealed compound heterozygosity for two point mutations that resulted in the amino acid substitutions T67M and R146Q, respectively. The impact of these mutations on ALG12 protein function was investigated in the Saccharomyces cerevisiae alg12 glycosylation mutant by showing that the yeast ALG12 gene bearing the homologous mutations T61M and R161Q and the human mutant ALG12 cDNA alleles failed to normalize the growth defect phenotype of the alg12 yeast model, whereas expression of the normal ALG12 cDNA complemented the yeast mutation. The ALG12 mannosyltransferase defect defines a new type of congenital disorder of glycosylation, designated CDG-Ig.
* To whom correspondence should be addressed. Tel: +41 16355080; Fax: +41 16356814; E-mail: thennet{at}access.unizh.ch
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Vleugels, L. Keldermans, J. Jaeken, T. D Butters, J.-C. Michalski, G. Matthijs, and F. Foulquier Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient Glycobiology, August 1, 2009; 19(8): 910 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Morava, H N Wosik, J Sykut-Cegielska, M Adamowicz, M Guillard, R A Wevers, D J Lefeber, and J R M Cruysberg Ophthalmological abnormalities in children with congenital disorders of glycosylation type I Br J Ophthalmol, March 1, 2009; 93(3): 350 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cohn, E. Eklund, A. L. Bergner, J. F. Casella, S. L. Woods, J. Althaus, K. J. Blakemore, H. E. Fox, J. E. Hoover-Fong, A. Hamosh, et al. Intracranial Hemorrhage as the Initial Manifestation of a Congenital Disorder of Glycosylation Pediatrics, August 1, 2006; 118(2): e514 - e521. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Schollen, C G Frank, L Keldermans, R Reyntjens, C E Grubenmann, P T Clayton, B G Winchester, J Smeitink, R A Wevers, M Aebi, et al. Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency) J. Med. Genet., July 1, 2004; 41(7): 550 - 556. [Full Text] [PDF] |
||||
![]() |
C. E. Grubenmann, C. G. Frank, A. J. Hulsmeier, E. Schollen, G. Matthijs, E. Mayatepek, E. G. Berger, M. Aebi, and T. Hennet Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik Hum. Mol. Genet., March 1, 2004; 13(5): 535 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wopereis, S. Grunewald, E. Morava, J. M. Penzien, P. Briones, M. T. Garcia-Silva, P. N.M. Demacker, K. M.L.C. Huijben, and R. A. Wevers Apolipoprotein C-III Isofocusing in the Diagnosis of Genetic Defects in O-Glycan Biosynthesis Clin. Chem., November 1, 2003; 49(11): 1839 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chantret, J. Dancourt, T. Dupre, C. Delenda, S. Bucher, S. Vuillaumier-Barrot, H. Ogier de Baulny, C. Peletan, O. Danos, N. Seta, et al. A Deficiency in Dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha 3-Glucosyltransferase Defines a New Subtype of Congenital Disorders of Glycosylation J. Biol. Chem., March 7, 2003; 278(11): 9962 - 9971. [Abstract] [Full Text] [PDF] |
||||






